Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs

E-ISSN： 1873-4286|15|14|1688-1698

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.14, 2009-05, pp. : 1688-1698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor

By Sheu-Meei Y. Zhi-Jiao C. Sheng-Chu K.

European Journal of Pharmacology, Vol. 280, Iss. 1, 1995-06 ,pp. : 69-77

Elsevier

Access to resources Recommend Favorite

Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis

By Taguchi I. Oka K. Kitamura K. Sugiura M. Oku A. Matsumoto M.

Inflammation Research, Vol. 48, Iss. 7, 1999-07 ,pp. : 380-385

Springer Publishing Company

Access to resources Recommend Favorite

Neurogenesis as a New Target for the Development of Antidepressant Drugs

Current Pharmaceutical Design, Vol. 20, Iss. 23, 2014-05 ,pp. : 3763-3775

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Phosphodiesterase 4-Mediated Cyclic AMP Signaling in Pharmacotherapy for Substance Dependence

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 355-364

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B 4 biosynthesis in human polymorphonuclear leukocytes

By Denis D. Riendeau D.

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 343-350

Elsevier

Access to resources Recommend Favorite